Osteoboost Blog | Insights on Bone Health and Innovation

World Osteoporosis Day: Closing the Innovation Gap in Women’s Musculoskeletal Health

Every year on World Osteoporosis Day, we’re reminded of a staggering reality: osteoporosis affects over 200 million people worldwide — most of them women.

Osteoboost is a TIME 2025 Best Inventions Winner: A Watershed Moment for Bone Health

We are thrilled to announce that TIME has named Osteoboost to its 2025 list of Best Inventions. This recognition is both incredibly exciting and humbling, not j

Empowering Women to Take Control of Their Bone Health: Osteoboost Launches Nationwide

Osteoboost, the first FDA-cleared device for osteopenia, is now available nationwide—helping women reduce bone loss with 30 minutes of daily use.

GLP-1 Medications and Low Bone Density: What You Need to Know to Protect Your Bones

GLP-1 drugs like Ozempic may reduce bone density. Learn how to protect your bones while on GLP-1s with exercise, nutrition, and new therapies.

Our latest press releases and news

Stay informed with the latest press releases, company announcements, and behind-the-scenes insights from the Osteoboost team.

October 21, 2025

New Study Shows Self-Guided Online Exercise Program Significantly Improves Strength and Reduces Fall Risk in Midlife and Older Women

October 21, 2025, REDWOOD CITY, CALIF — A new study to be presented at The Menopause Society (TMS) 2025 Annual Meeting by Osteoboost Health...

Osteoboost Presents Clinical Trial Data Demonstrating High Adherence and Usability for Osteopenia at ENDO 2025

A 12-month randomized, sham-controlled clinical trial has found that Osteoboost, the first and only FDA-cleared prescription medical device for low...

Osteoboost Health Launches FDA-Cleared Prescription Wearable Device for Low Bone Density, Filling Critical Treatment Gap for 60M+ Americans

Osteoboost Health, Inc today announced the nationwide availability of Osteoboost, the first and only FDA-cleared prescription medical device for...

Osteoboost in the headlines

Explore media highlights and articles featuring Osteoboost’s impact and innovation.

You Can Now Wear This Belt to Help Prevent Osteoporosis

KTLA covers Osteoboost, the FDA‑cleared wearable belt using vibration therapy to strengthen bones and help prevent osteoporosis in postmenopausal women.

This New Wearable Uses NASA Technology to Reverse Bone Loss

Oprah Daily spotlights Osteoboost, an FDA-cleared wearable using NASA-inspired tech to combat bone loss in postmenopausal women.

Good Vibrations: A New FDA-Approved Device Could Offer a Solution for Osteopenia Treatment

Endocrine News spotlights Osteoboost, the first FDA-cleared wearable delivering targeted vibration therapy to slow bone loss in postmenopausal women.